Comparison of methadone and slow-release morphine maintenance in pregnant addicts

Addiction

Volumn 94, Issue 2, 1999, Pages 231-239

  Fischer, Gabriele ^a   Jagsch, Reinhold ^a   Eder, Harald ^a   Gombas, Wolfgang ^a   Etzersdorfer, Petra ^a   Schmidl Mohl, Katrin ^b   Schatten, Christian ^b   Weninger, Manfred ^b   Aschauer, Harald N ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; METHADONE; MORPHINE; NICOTINE; PHENOBARBITAL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG URINE LEVEL; FEMALE; HUMAN; NEWBORN; ORAL DRUG ADMINISTRATION; PREGNANCY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; URINALYSIS; WITHDRAWAL SYNDROME;

EID: 0032930990     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1999.9422317.x     Document Type: Article

References (42)

1. ALLEN, P. M. & SANDLER, M. (1993) Critical components of obstetric management of chemically dependent women, Clinical Obstetrics and Gynecology, 36, 347-360.
2. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (Washington, DC, American Psychiatric Association).
3. BLINICK, G., JEREZ, E. & WALLACH, R. C. (1973) Methadone maintenance, pregnancy and progeny, Journal of the American Medical Association, 225, 477-479.
4. BORTZ, J. (1988) Statistik für Sozialwissenschaftler (Springer-Verlag, Berlin).
5. BROWN, E. & ZUCKERMAN, B. (1991) The infant of the drug abusing mother, Pediatric Annals, 20, 555-563.
6. CHASNOFF, I. J. (1989) Drug use and women: establishing a standard of care, Annals of the New York Academy of Science, 562, 208-210.
7. CHASNOFF, I. J., BUSSEY, M. E., SAVICH, R. & STACK, C. M. (1986) Perinatal cerebral infarction and maternal cocaine use, Journal of Pediatrics, 108, 456-459.
8. CHASNOFF, I. J., LANDRESS, H. & BARETT, M. (1990) The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida, New England Journal of Medicine, 322, 1202-1206.
9. CHIANG, C. N., & FINNEGAN, L. P. (Eds) (1995) Medications Development for the Treatment of Pregnant Addicts and their Infants, NIDA Research Monograph 149 (Rockville, MD, US Department of Health and Human Services, Public Health Service, National Institutes of Health).
10. CLONINGER, C. R., SURATRIC, D. M. & PRZYBECK, T. R. (1993) A psychobiological model of temperament and character, Archives of General Psychiatry, 50, 975-990.
11. DELEON, G. & JAINCHILL, N. (1991) Residential therapeutic communities for female substance abusers, Bulletins of the New York Academy of Medicine, 67, 277-290.
12. DIXON, S. D. & BEJAR, R. (1989) Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates, Journal of Pediatrics, 115, 770-778.
13. DOBERCZAK, T. M., KANDALL, S. R. & FRIEDMANN, P. (1993) Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and noenatal withdrawal, Obstetrics and Gynecology, 81, 936-940.
14. DOLE, V. P. & NYSWANDER, M. (1965) A medical treatment for diacethylmorphine (heroin) addiction, Journal of the American Medical Association, 193, 80-84.
15. EMIT® ASSAY TROUBLESHOOTING GUIDE (1983) Syva Co., Palo Alto, CA.
16. ETZERSDORFER, P., FISCHER, G., EDER, H., JAGSCH, R., SCHMIDL-MOHL, K. & GOMBAS, W. (1997) Comparison of morphine and methadone maintenance in pregnant opiate addicts, NIDA Research Monograph Series, 178, 343.
17. EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION (1996) Annual Report on the State of the Drugs Problem in the European Union, European Communities (1100 Lisbon, Portugal Rua Cruz de Santa Apolonia, 23/25).
18. FAGERSTRÖM, K. O. (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualisation of treatment, Addictive Behaviors, 3, 235-241.
19. FINNEGAN, L. P. (1976) Clinical effects of pharmacologic agents on pregnancy and the neonate, Annals of the New York Academy of Science, 281, 74-89.
20. FINNEGAN, L. P. (1978) Management of pregnant drug-dependent women, Annals of the New York Academy of Science, 311, 153-146.
21. FINNEGAN, L. P. (1995) Addiction and pregnancy: maternal and child issues, in: TAGLIAMONTE, A. & MAREMANI, I. (Eds) Drug Related Clinical Problems, pp. 137-147 (Springer-Verlag, Vienna).
22. FINNEGAN, L. P. & EHRLICH, S. M. (1990) Maternal drug abuse during pregnancy: evaluation and pharmacotherapy for neonatal abstinence, Modern Methods in Pharmacology, Testing Evaluation of Drugs of Abuse, 6, 255-263.
23. FINNEGAN, L. P. & KALTENBACH, K. (1992) Neonatal abstinence syndrome, in: HOEKELMAN, R. A., FRIEDMAN, S. B., NELSON, N. & SEIDEL, H. M. (Eds) Primary Pediatric Care, 2nd edn, pp. 1367-1378 (St Louis, CV Mosby).
24. FINNEGAN, L. P. & KANDALL, S. R. (1992) Maternal and neonatal effects of alcohol and drugs, in: LOWINSON, J. H., RUIZ, P. & MILLMAN, R. B. (Eds), LANGROD, J. G. (Assoc.Ed.) Substance Abuse, A Comprehensive Textbook, 2nd edn, pp. 628-656 (Baltimore, Williams and Wilkins).
25. FISCHER, G., PRESSLICH, O., DIAMANT, K., SCHNEIDER, C., PEZAWAS, L. & KASPER, S. (1996) Oral morphine-sulphate in treatment of opiate dependent patients, Alcoholism, 32, 35-43.
26. GILES, W., PATTERSON, T., SANDERS, R. N., BATEY, R., THOMAS, D. & COLLINS, J. (1989) Outpatient methadone program for pregnant heroin using woman, Australian and New Zealand Journal of Obstetrics and Gynaecology, 29, 225-229.
27. GILLOGLEY, K. M., EVANS, A. T. & HANSEN, R. L. (1990) The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening, American Journal of Obstetrics and Gynecology, 163, 1535-1542.
28. HAGAN, T. A., FINNEGAN, L. P. & NELSON-ZLUPKO, L. (1994) Impediments to comprehensive treatment models for substance-dependent women: treatment and research questions, Journal of Psychoactive Drugs, 26/2, 163-171.
29. JARVIS, M. A. E. & SCHNOLL, S. H. (1995) Methadone use during pregnancy, NIDA Research Monograph, 149, 58-77.
30. KANDALL, S. R. (1995) Treatment options for drug-exposed infants, NIDA Research Monograph, 149, 78-99.
31. KANDALL, S. R., ALBIN, S., GARTNER, L. M., LEE, K. S., EIDELMAN, A. & LOWINSON, J. (1977) The narcotic-dependent mother: fetal and neonatal consequences, Early Human Development, 1/2, 159-169.
32. KANDALL, S. R., DOBERCZAK, T. M., MAUER, K. R., STRASHUM, R. H. & KORTS, D. C. (1983) Opiate v CNS depressant therapy in neonatal drug abstinence syndrome, American Journal of Diseases of Children, 137, 378-382.
33. KALTENBACH, K. & FINNEGAN, L. P. (1986) Neonatal abstinence syndrome, pharmacotherapy and developmental outcome, Neurobehavioural Toxicology and Teratology, 8, 353-355.
34. KREEK, M. J. (1979) Methadone disposition during the perinatal period in humans, Pharmacology, Biochemistry and Behavior, 11, 7-13.
35. KREEK, M. J., SCHECTER, A., GUTJAHR, C. L., BOWEN, D., FIELD, F., QUEENAN, J. & MERKATZ, I. (1974) Analysis of methadone and other drugs in maternal and neonatal body fluids: use in evaluation of syndromes in a nconate of mother maintained in methadone, American Journal of Drug and Alcohol Abuse, 1, 409-419.
36. MCLELLAN, A., KUSHNER, H. & METZGER, D. et al. (1992) Addiction severity index, 5th edn, Journal of Substance Abuse and Treatment, 9, 199-213.
37. SCHNEIDER, C., FISCHER, G. & DIAMANT, K. et al. (1996) Schwangerschaft und Drogenabhängigkeit, Wiener Klinische Wochenschrift, 108, 611-614.
38. US DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE (1980) The health consequences of smoking for women: a report of the Surgeon General (Washington, DC, USDHHS).
39. SZETO, H. H. (1995) Opioid receptor approaches for the development of medications for pregnant women, NIDA Research Monograph, 149, 100-115.
40. WANG, R. I. H., WIESEN, R. L., LAMID, S. & ROH, B. L. (1974) Rating the presence and severity of opiate dependence, Clinical Pharmacology and Therapeutics, 7, 653-658.
41. WOODS, J. R. (1995) Clinical management of drug dependency in pregnancy, NIDA Research Monograph, 149, 39-57.
42. ZUCKERMANN, B. & BROWN, E. (1993) Maternal substance abuse and infant development, in: TSANG, R. (Ed.) Handbook of Infant Mental Health, pp. 143-158 (New York, Guilford Press).